Académique Documents
Professionnel Documents
Culture Documents
The reduction in the number of RBCs or the amount of Hgb or Hct. A clinical manifestation NOT a specific disease Can occur with many health problems Many types and causes Can result from Dietary problems Genetic disorders Bone marrow disease Excessive bleeding
Hemolytic anemia Many forms of hemolytic anemia More than 200 disorders have been identified. Jaundice Destroyed RBCs cause bilirubin Enlarged spleen and liver Hyperactive with macrophage phagocytosis of the defective RBCs Accumulation of the hemoglobin molecules can obstruct renal tubules Tubular necrosisMajor focus of treatment is to maintain renal function
G6PD
(congenital) Glucose-6phosphate dehydrogenase Screening for this deficiency is necessary before donating blood, because cells deficient in G6PD can be hazardous. Pt. is usually asymptomatic until exposed to infection or certain drugs i.e..) sulfonamides, aspirin, quinine derivatives, thiazide diuretics, high doses of vitamin C Treatment Hydration Osmotic diuretics Transfusions
Aplastic anemia
RBCs are viewed as non-self by the immune system Immune system products attack a persons own RBCs for unknown reasons. 2 types:
Warm antibody Cold antibody
Management
Diet 10-15mg of iron per dayonly 5-10% of dietary iron is absorbed Red meat, organ meat (liver), egg yolks, kidney beans, leafy green vegetables, and raisins Oral iron supplements Ferrous sulfate IM iron solutions if anemia is severe
Treatment
Management depends on severity of symptoms
Steroid therapy - 1st line of treatment Splenectomy Intense immunosuppressive therapy Cytoxan Imuran Plasma exchange
Management
Diet Animal proteins, eggs, nuts, dairy products, dried beans, citrus fruit, leafy green vegetables Vitamin supplements if severe Shilling test for pernicious anemia Measures the presence of Vitamin B12 in the urine after the pt is given an oral dose of radioactive Vitamin B12 Monthly B12 injections for pernicious anemia CaloMist nasal spray
A deficiency of circulating RBCs because of failure of the BM to produce these cells. Can be caused by long-term exposure to ionizing radiation or infection. Usually occurs along w/ leukopenia (low WBC) and thrombocytopenia (low plts). Pancytopenia- a deficiency of all 3 cell types Quite common in aplastic anemia
Treatment
Blood transfusions are the main course of treatment. Immunosuppressive therapy helps pts. w/ types of aplastic anemia that have a similar disease course to that of autoimmune problems. BM transplant replaced defective stem cells and can cure the disorder. Splenectomy
Management
Prevention Identify highrisk patients Diet Scheduled folic acid replacement therapy
Manitol
Splenectomy
May be performed for pts w/ an enlarged spleen that is either destroying normal RBCs or suppressing their development. Infection
Rememberspleen performs many immune protection functions!
Polycythemia Vera
A cancer of the RBCs 3 Major Hallmarks 1. massive production of RBCs 2. excessive leukocyte production 3. excessive production of platelets. Disease with sustained increase in blood Hgb levels to 18 g/dL, RBC count of 6 million/mm3, or a Hct of 55% or >. Pts facial skin and mucous membranes are dark and flushed in appearance. Areas appear purplish and cyanotic. Pts c/o severe itching caused by dilated blood vessels and varied tissue oxygenation. Superficial veins are visibly distended Blood is thick and slow moving, placing increased demands on the heart, causing hypertension. Hypoxia
Myelodysplastic Syndromes
A group of disorders caused by the formation of abnormal cells in the BM. The abnormal cells are usually destroyed after being released into the bloodstream. Has cancer-like features and is considered to be a precursor to cancer. Many subtypes 30% of patients with MDS will develop acute leukemia Anemia Neutropenia/Thrombocytopenia
Hemachromatosis
A disorder of iron regulation. Inherited disease where excess free iron is deposited in various organs including the liver and pancreas. Iron exists in 2 states: Ferrous (state of free iron, very toxic) ferric The free radicals damage cells and tissues, leading to inflammation, cirrhosis of the liver, diabetes, spleen, pancreas and cardiac problems. The chemical properties of iron cannot be broken down and eliminated, leading to iron overload. Occurs more frequently in men Often a silent disorder Not often detected until permanent damage has occurred
Risk Factors
Normal physiological changes associated with aging Chemical exposures
Pesticides, benzene
Treatment
Malignant disease Progresses in severity over time. If untreated, death occurs. Few live longer than 2yrs after diagnosis if untreated. Conservative treatment of repeated phlebotomies (2-5 times per wk) can prolong life 10-15 yrs. Removing the RBCs to decrease the # thereby reducing blood viscosity. Treatment aims to prevent clot formation and includes anticoagulants.
Treatment
Focuses on symptom management and supportive care
Blood transfusions for anemia Platelet transfusions for severe thrombocytopenia Deferasirox (Exajade) Deferoxamine mesylate (Desferal, Desferrioxamine)
Chelation therapy